Skip to main content

Advertisement

Log in

The importance of genomic copy number changes in the prognosis of glioblastoma multiforme

  • Neurooncology
  • Published:
Neurosurgical Review Aims and scope Submit manuscript

Abstract

Glial tumors are the most common tumors of the nervous system, affecting individuals at any age. Since understanding of the molecular pathologies underlying human gliomas is still very poor, the treatment and therefore prognosis of this malignancy could not yet be improved. In order to determine whether different glioblastoma-associated genomic aberrations may serve as prognostic markers in combination with histopathological findings, 20 primary glioblastoma multiforme tumors were screened by comparative genomic hybridization, and the results were compared with histopathological and clinical features. All tumors showed genomic copy aberrations detected by comparative genomic hybridization. Regional and numerical increases in chromosome 7 copy number were the most frequently seen abnormality (10/20 tumors), followed by loss of chromosome 10 (8/20). Both of these aberrations were associated with shorter surveillance time. Chromosome 12q amplification was detected in seven tumors. Loss of 17p, 1p, and 19q in combination was seen in three cases. One of them was a giant cell GBM, whereas the remaining two cases were still alive. Combination of chromosome 1p and 19q deletions was also seen in a case with long surveillance. According to the preliminary findings of this study, in addition to the EGFR gene, amplification of other genes on chromosome 7 and the deletion of PTEN gene and other cancer-related genes on chromosome 10 appeared important to the development of glioblastoma multiforme and were associated with poor prognosis, whereas the combination of chromosome 1p and 19q deletions seems to be an informative molecular marker for better prognosis. The clinical features and genetic alterations of primary and secondary glioblastoma multiforme should be compared in large series to clarify the effective prognostic markers; and further molecular analyses focused on chromosomes 7 and 10 will be very helpful for understanding the molecular mechanisms underlying the progression of glioblastoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

References

  1. Scott, JN, Rewcastle NB, Brasher PM, Fulton D, Hagen N, MacKinnon JA, Sutherland G, Cairncross JG, Forsyth P (1998) Long term glioblastoma multiforme survivors: a population based study. Can J Neurol Sci 25:197–201

    CAS  PubMed  Google Scholar 

  2. Cooper GM (1997) The cell. Oxford University Press, New York

  3. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavanee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215–225

    PubMed  Google Scholar 

  4. Schmidt MC, Antweiler S, Urban N, Mueller W, Kuklik A, Meyer-Puttlitz B, Wiestler OD, Louis DN, Fimmers R, Von Deimling A (2002) Impact of genotype and morphology on the prognosis of glioblastoma. J Neuropathol Exp Neurol 61:321–328

    CAS  PubMed  Google Scholar 

  5. Burger PC, Vollmer RT (1980) Histologic factors of prognostic significance in the glioblastoma multiforme. Cancer 46:1179–1186

    CAS  PubMed  Google Scholar 

  6. Burger PC, Vogel FS, Green SB, Strike TA (1985) Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56:1106–1111

    CAS  PubMed  Google Scholar 

  7. Jung V, Romeike FM, Henn W, Feiden W, Moringlane JR, Zang KD, Urbschat S (1999) Evidence of focal genetic microheterogenity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells. J Neuropathol Exp Neurol 58:993–999

    Google Scholar 

  8. Rey JA, Bello MJ, de Campos JM, Kusak ME, Moreno S (1987) Chromosomal composition of a series of 22 human low-grade gliomas. Cancer Genet Cytogenet 29:223–237

    Article  CAS  PubMed  Google Scholar 

  9. Bigner SH, Mark J, Burger PC, Mahaley MS, Bullar DE, Muhlbaier LH, Bigner DD (1988) Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 88:405–411

    Google Scholar 

  10. Brunner C, Jung V, Henn W, Zang KD, Urbschat S (2000) Comparative genomic hybridization reveals recurrent enhancements on chromosome 20 and in one case combined amplification sites on 15q24q26 and 20p11p12 in glioblastomas. Cancer Genet Cytogenet 121:124–127

    Article  CAS  PubMed  Google Scholar 

  11. Schröck E, Thiel G, Lozanova T, du Manoir S, Meffert M-C, Jauch A, Speicher MR, Nürnberg P, Vogel S, Janisch W, Donis-Keller H, Ried T, Witkowski R, Cremer T (1994) Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am J Pathol 144:1203–1218

    PubMed  Google Scholar 

  12. Weber R, Sommer C, Albert F, Kiessling M, Cremer T (1996) Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybridization. Lab Invest 74:108–119

    CAS  PubMed  Google Scholar 

  13. Mao X, Hamoudi RA (2000) Molecular and cytogenetic analysis of glioblastoma multiforme. Cancer Genet Cytogenet 122:87–92

    Article  CAS  PubMed  Google Scholar 

  14. Maruno M, Yoshimine T, Ghulam Muhammad AKM, Ninomiya H, Kato A, Hayakawa T (1999) Chromosomal aberrations detected by comparative genomic hybridization (CGH) in human astrocytic tumors. Cancer Lett 135:61–66

    Article  CAS  PubMed  Google Scholar 

  15. Weber RG, Sabel M, Reifenberger J, Sommer C, Oberstrass J, Reifenberger G, Kiessling M, Cremer T (1996) Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene 13:983–994

    CAS  PubMed  Google Scholar 

  16. Arslantas A, Artan S, Oner U, Durmaz R, Muslumanoglu MH, Atasoy MA, Basaran N, Tel E (2002) Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas. Acta Neurol Belg 102:53–62

    PubMed  Google Scholar 

  17. Durmaz R, Erken S, Arslantas A, Atasoy MA, Bal C, Tel E (1997) Management of glioblastoma multiforme: with special reference to recurrence. Clin Neurol Neurosurg 99:117–123

    Article  CAS  PubMed  Google Scholar 

  18. Obwegeser A, Ortler M, Seiwald M, Ulmer H, Kostron H (1995) Therapy of glioblastoma multiforme. A cumulative experience of 10 years. Acta Neurochir (Wien) 137:29–33

    Google Scholar 

  19. Romeike BFM, Jung V, Feiden W, Moringlane JR, Zang KD, Urbschat SM (2001) Distribution of epidermal growth factor receptor protein correlates with gain in chromosome 7 revealed by comparative genomic hybridization after microdissection in glioblastoma multiforme. Pathol Res Pract 197:427–431

    CAS  PubMed  Google Scholar 

  20. Schlegel J, Scherthan H, Arens N, Stumm G, Kiessling M (1996) Detection of complex genetic alterations in human glioblastoma multiforme using comparative genomic hybridization. J Neuropathol Exp Neurol 55:81–87

    Google Scholar 

  21. Sano T, Lin H, Chen X, Langford LA, Koul D, Bondy ML, Hess KR, Myers JN, Hong K, Yung WK, Steck PA (1999) Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res 59:1820–1824

    CAS  PubMed  Google Scholar 

  22. Leenstra S, Bijlsma EK, Troost D, Oosting J, Wesrerveld A, Bosch DA, Hulsebos TJM (1994) Allele loss on chromosome 10 and 17p and epidermal growth factor receptor amplification in human malignant astrocytoma related to prognosis. Br J Cancer 70:684–689

    CAS  PubMed  Google Scholar 

  23. Balesaria S, Brock C, Bower M, Clark J, Nicholson SK, Lewis P, de Sanctis S, Evans H, Peterson D, Mendoza N, Glaser MG, Newlands ES, Fisher RA (1999) Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas. Br J Cancer 81:1371–1377

    Article  CAS  PubMed  Google Scholar 

  24. Teich NM (1998) Oncogenes and cancer. In: Franks LM, Teich NM (eds) Cellular and molecular biology of cancer. Oxford University Press, NewYork, pp 169–201

  25. Lang FF, Miller DC, Koslow M, Newcomb EW (1994) Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 81:427–436

    Google Scholar 

  26. Watanabe K, Tachibana O, Sato K, Yonekawa Y, Kleihues P, Ohgaki H (1996) Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 6:217–223

    Google Scholar 

  27. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP (1994) Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 145:1175–1190

    CAS  PubMed  Google Scholar 

  28. Bigner SH, Matthews MR, Rasheed BKA, Wiltshire RN, Friedman HS, Friedman AH, Stenzel TT, Dawes DM, McLendon RE, Bigner DD (1999) Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. Am J Pathol 155:375–386

    CAS  PubMed  Google Scholar 

  29. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90:1473–1479

    CAS  PubMed  Google Scholar 

  30. Ino Y, Betensky RA, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, Ramsay DA, Cairncross JG, Louis DN (2001) Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res 7:839–845

    CAS  PubMed  Google Scholar 

  31. Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB (2000) Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas and mixed oligoastrocytomas. J Clin Oncol 18:636–645

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ali Arslantas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arslantas, A., Artan, S., Öner, Ü. et al. The importance of genomic copy number changes in the prognosis of glioblastoma multiforme. Neurosurg Rev 27, 58–64 (2004). https://doi.org/10.1007/s10143-003-0279-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10143-003-0279-4

Keywords

Navigation